Clinical Lung Cancer

译名:临床肺癌

SCIEJCR Q2中科院3区

3-5

2026

影响因子区间

108天

平台估算

投稿周期

16%

2025

中国作者发文占比

USD 3,290

费用说明

收费

期刊简介:Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

【译文】临床肺癌是一本同行评审的双月刊,发表描述肺癌临床和转化研究各个方面的原创文章。临床肺癌致力于关于肺癌的检测、诊断、预防和治疗的文章。主要强调与肺癌相关的所有领域的最新科学发展。具体感兴趣的区域包括临床研究和机制方法;药物敏感性和耐药性;基因和反义治疗;病理学、标志物和预后指标;化学预防策略;多模式治疗以及各种方法的整合。

出版社
Elsevier BV
语言
English
学科
医学
ISSN
1525-7304
eISSN
1938-0690
出版频率
双月刊
创刊年份
1999
投稿网址
https://www.editorialmanager.com/CLC
最近更新
2026-04-02 18:16:40
Clinical Lung Cancer

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区3区
暂无
影响因子区间3-5
暂无